0.92
-0.015(-1.60%)
Currency In USD
| Previous Close | 0.94 |
| Open | 0.9 |
| Day High | 0.93 |
| Day Low | 0.9 |
| 52-Week High | 23.77 |
| 52-Week Low | 0.69 |
| Volume | 61,100 |
| Average Volume | 2.9M |
| Market Cap | 11.51M |
| PE | -0.17 |
| EPS | -5.41 |
| Moving Average 50 Days | 1.39 |
| Moving Average 200 Days | 5.47 |
| Change | -0.02 |
SCIENTURE announces manufacturing and supply chain readiness for ArbliTM, (losartan potassium) Oral Suspension, 10mg/mL for a target product launch in July 2025.
GlobeNewswire Inc.
Apr 22, 2025 12:05 PM GMT
TAMPA, FL, April 22, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through d
SCIENTURE announces the divestiture of its legacy subsidiaries for a total consideration of $5 million and dedicates its full focus to the Branded and Specialty Pharma segment through Scienture, LLC.
GlobeNewswire Inc.
Apr 08, 2025 12:05 PM GMT
TAMPA, FL, April 08, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) (the “Company”), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and car
Scienture Holdings, Inc. Issues Annual Letter to Shareholders
GlobeNewswire Inc.
Apr 03, 2025 12:26 PM GMT
TAMPA, FL, April 03, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through d